Propel testing excellence with Mayo Clinic quality
Mayo Clinic Laboratories is a one-stop laboratory solution, offering commercial laboratories a vast testing menu, unparalleled customer service, and optimized processes. We work collaboratively with partners to assess their needs, providing the testing they need to expand into new areas and meet their business goals.
As the reference lab for Mayo Clinic, we’ve developed robust logistics and testing protocols applied uniformly for all specimens received, no matter their geographic origin. Whether you send us one test order or thousands, each sample receives the same treatment and level of care, ensuring superior results that help our partners better serve their clients.
“Our clients want personal experiences. They want someone to answer the phone. They want someone to provide answers when they're looking for results of a sample sent a couple days ago. and we deliver those answers.”
Angie Reese-Davis, director of operations, logistics, and specimen services, Mayo Clinic Laboratories
Our difference
News and updates
The latest
In this episode of the “Leveraging the Laboratory” podcast, Jane Hermansen, outreach manager at Mayo Clinic Laboratories, welcomes Chelsea Conn, Mayo Clinic Laboratories’ director of regulatory affairs. Together, they break down the latest regulatory changes and share actionable strategies to help outreach programs stay informed and prepared.
Dr. Bill Morice explores how the data revolution is shaping clinical diagnostics as it drives healthcare transformation at an unprecedented pace.
Mayo Clinic Laboratories is transforming diagnostics with innovations in 2025 that turned research into real-world solutions for better patient care.
Discover an overview of common acronyms that laboratory outreach leaders may encounter in their daily work and links to help you learn more.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent news updates and key advancements shaping the industry in 2025.
Register now – Feb. 18, 2026 - PACE/FL - Review the latest evidence, guidelines, strategies, and testing solutions for differentiating metabolic from alcohol-related liver injury.
Tuesday, March 10, 202611 a.m.–Noon CT Cost Free for all participants. Overview This webinar introduces real-time quaking-induced conversion (RT-QuIC) assays that are now available at[...]
We wish you a joyful holiday season and look forward to continuing our collaboration in 2026.
Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered due to the upcoming New Year's holiday. To ensure specimen stability and prevent delays, follow the guidelines outlined below for domestic clients and international clients.
Discuss ways to become an effective coach and guide your colleagues and teams toward improvements and successes.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and the first reported death from alpha-gal syndrome. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories’ chief digital innovation officer and medical director of BioPharma Diagnostics, to explore how biopharma diagnostics advance research and development.
April 28, 2025 - Inflammatory bowel disease (IBD) is classified as either Crohn’s disease or ulcerative colitis, based on clinical presentation, endoscopic findings, histopathology, and disease distribution.
November 3, 2025 - In this video, Dr. Andrew McKeon describes how the field of autoimmune neurology testing has changed with the explosion of antibody discovery and discusses the importance of a patient-first, phenotype-based approach.